These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37882920)

  • 1. Association of physical weight statuses defined by body mass index (BMI) with molecular subtypes of premenopausal breast cancer: a systematic review and meta-analysis.
    Li X; Li J; Hu Q; Zhang X; Chen F
    Breast Cancer Res Treat; 2024 Feb; 203(3):429-447. PubMed ID: 37882920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the Interaction Between Mammographic Breast Density, Body Mass Index, and Menopausal Status With Breast Cancer Risk Among Korean Women.
    Tran TXM; Moon SG; Kim S; Park B
    JAMA Netw Open; 2021 Dec; 4(12):e2139161. PubMed ID: 34940866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between body mass index and immunohistochemical subtypes in breast cancer.
    Sahin S; Erdem GU; Karatas F; Aytekin A; Sever AR; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():227-236. PubMed ID: 27756509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of breast cancer subtypes and body mass index.
    Petekkaya I; Sahin U; Gezgen G; Solak M; Yuce D; Dizdar O; Arslan C; Ayyildiz V; Altundag K
    Tumori; 2013; 99(2):129-33. PubMed ID: 23748802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.
    Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
    J BUON; 2013; 18(2):335-41. PubMed ID: 23818343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
    Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
    Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Body mass index and cancer incidence:a prospective cohort study in northern China].
    Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer.
    Chen L; Cook LS; Tang MT; Porter PL; Hill DA; Wiggins CL; Li CI
    Breast Cancer Res Treat; 2016 Jun; 157(3):545-54. PubMed ID: 27220749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal association between Body mass index (BMI), BMI trajectories and the risk of frailty among older adults: A systematic review and meta-analysis of prospective cohort studies.
    Sun Q; Xia X; He F
    Arch Gerontol Geriatr; 2024 Sep; 124():105467. PubMed ID: 38728821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis.
    Amadou A; Ferrari P; Muwonge R; Moskal A; Biessy C; Romieu I; Hainaut P
    Obes Rev; 2013 Aug; 14(8):665-78. PubMed ID: 23615120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of weight status and the risks of diabetes in adults: a systematic review and meta-analysis of prospective cohort studies.
    Yu HJ; Ho M; Liu X; Yang J; Chau PH; Fong DYT
    Int J Obes (Lond); 2022 Jun; 46(6):1101-1113. PubMed ID: 35197569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention.
    Wang F; Liu L; Cui S; Tian F; Fan Z; Geng C; Cao X; Yang Z; Wang X; Liang H; Wang S; Jiang H; Duan X; Wang H; Li G; Wang Q; Zhang J; Jin F; Tang J; Li L; Zhu S; Zuo W; Ma Z; Zhou F; Yu L; Xiang Y; Li L; Shen S; Yu Z
    Oncologist; 2017 Dec; 22(12):1431-1443. PubMed ID: 28912152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis.
    Cheraghi Z; Poorolajal J; Hashem T; Esmailnasab N; Doosti Irani A
    PLoS One; 2012; 7(12):e51446. PubMed ID: 23236502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of established risk factors with breast cancer subtypes.
    McCarthy AM; Friebel-Klingner T; Ehsan S; He W; Welch M; Chen J; Kontos D; Domchek SM; Conant EF; Semine A; Hughes K; Bardia A; Lehman C; Armstrong K
    Cancer Med; 2021 Sep; 10(18):6456-6467. PubMed ID: 34464510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.
    Fagherazzi G; Chabbert-Buffet N; Fabre A; Guillas G; Boutron-Ruault MC; Mesrine S; Clavel-Chapelon F
    Int J Obes (Lond); 2012 Mar; 36(3):431-9. PubMed ID: 21427693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body size and weight change over adulthood and risk of breast cancer by menopausal and hormone receptor status: a pooled analysis of 20 prospective cohort studies.
    van den Brandt PA; Ziegler RG; Wang M; Hou T; Li R; Adami HO; Agnoli C; Bernstein L; Buring JE; Chen Y; Connor AE; Eliassen AH; Genkinger JM; Gierach G; Giles GG; Goodman GG; Håkansson N; Krogh V; Le Marchand L; Lee IM; Liao LM; Martinez ME; Miller AB; Milne RL; Neuhouser ML; Patel AV; Prizment A; Robien K; Rohan TE; Sawada N; Schouten LJ; Sinha R; Stolzenberg-Solomon RZ; Teras LR; Tsugane S; Visvanathan K; Weiderpass E; White KK; Willett WC; Wolk A; Zeleniuch-Jacquotte A; Smith-Warner SA
    Eur J Epidemiol; 2021 Jan; 36(1):37-55. PubMed ID: 33128203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
    Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factor Analysis for Breast Cancer in Premenopausal and Postmenopausal Women of Punjab, India.
    Kour A; Sharma S; Sambyal V; Guleria K; Singh NR; Uppal MS; Manjari M; Sudan M; Kukreja S
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3299-3304. PubMed ID: 31759352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early adulthood overweight and obesity and risk of premenopausal ovarian cancer, and premenopausal breast cancer including receptor status: prospective cohort study of nearly 500,000 Danish women.
    Urbute A; Frederiksen K; Kjaer SK
    Ann Epidemiol; 2022 Jun; 70():61-67. PubMed ID: 35405346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial.
    Wang H; Yee D; Potter D; Jewett P; Yau C; Beckwith H; Watson A; O'Grady N; Wilson A; Brain S; Pohlmann P; ; Blaes A
    Breast Cancer Res Treat; 2024 Apr; 204(3):589-597. PubMed ID: 38216819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.